Fibromyalgia Treatment in Baltimore
When you've tried what was supposed to work — and it hasn't been enough.
Fibromyalgia treatment in Baltimore with IV ketamine costs $1,499.99 per session ($1,125 for Vitality Circle members — a $374.99 saving) and is anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD, a board-certified Johns Hopkins anesthesiologist. It is an evidence-based pathway for patients whose standard care has fallen short. If pregabalin (Lyrica), duloxetine (Cymbalta), or milnacipran (Savella) haven't given you the relief you needed — and physical therapy and sleep work have helped only at the margins — IV ketamine infusion is one option we may discuss. Ketamine is the most direct mechanism currently available against central sensitization, the nervous-system process that drives fibromyalgia. We evaluate refractory fibromyalgia patients honestly: it is off-label, it is not a cure, and it is a conversation about whether it fits your situation.
Mon–Fri 1PM–8PM · Sat 10AM–2PM
513 Bayview Blvd, Canton, Baltimore MD 21224
(443) 563-1059
Tell Us About Your Situation
Answer a few quick questions about your fibromyalgia history and what you've tried. Our clinical team reaches out within 1 business day.
Your information is confidential. A clinical team member follows up within 1 business day.
You're Not Imagining This — And You're Not Alone
If this sounds like you, you are in good company. Fibromyalgia affects an estimated 10 million Americans, and many of them are people who have cycled through pregabalin (Lyrica), duloxetine (Cymbalta), physical therapy, and rheumatology referrals without meaningful relief. The reason your tests come back normal isn't because nothing is wrong — it's because fibromyalgia is a central nervous system condition rather than a peripheral tissue disease. The abnormality is in how the nervous system processes signals, not in your joints or muscles. That process is measurable and well-documented in the research, even when an MRI of the joints isn't.
At Vita Nova, fibromyalgia is treated as the neurobiological condition it is — not a psychosomatic complaint. We listen to your full history first. We review what's been tried. And then we have an honest conversation about whether ketamine infusion therapy may be a reasonable next step, or whether it isn't.
What "Refractory" Means — And Why We Take It Seriously
There is no single consensus medical definition of refractory fibromyalgia. That ambiguity has left many patients in a difficult place — their symptoms persist, their treatments are listed as "first-line," and their clinicians don't always know what to offer next. At Vita Nova, refractory fibromyalgia is taken seriously as a defined clinical situation, even when the broader medical community has not formalized the term.
In practice, we use the following working definition when evaluating refractory fibromyalgia patients:
- A confirmed fibromyalgia diagnosis from a qualified clinician, with other conditions ruled out
- Documented trial of at least two FDA-approved fibromyalgia medications — pregabalin (Lyrica), duloxetine (Cymbalta), or milnacipran (Savella) — at therapeutic doses
- Trial of, or insufficient benefit from, physical therapy, cognitive behavioral therapy, exercise programs, and sleep optimization
- Continued clinically significant pain, fatigue, or functional impairment despite the above
This is the patient group most likely to be considered for ketamine evaluation at Vita Nova. If this describes you, the next step is a clinical conversation — not a prescription, not a sales pitch, just a structured evaluation of whether ketamine infusion may fit your situation.
FDA-Approved Fibromyalgia Medications — The Pathway Before Ketamine
Fibromyalgia is one of the few chronic pain conditions with FDA-approved disease-specific medications. These should be evaluated with your physician before ketamine is considered. We review your prior treatment history during clinical evaluation — not to gatekeep, but to make sure you've had a fair shot at the established options before considering off-label alternatives.
These are the established pharmacological options. If you haven't tried them — or haven't tried them at therapeutic doses — that is the conversation to have with your primary care physician or rheumatologist first.
Alpha-2-delta calcium channel ligand. Reduces abnormal pain signaling in sensitized neurons by modulating calcium influx. The first medication approved specifically for fibromyalgia. Available by prescription from your PCP or neurologist.
Serotonin-norepinephrine reuptake inhibitor (SNRI). Strengthens descending pain inhibitory pathways from the brain to the spinal cord. Also used for depression, anxiety, and diabetic neuropathy — helpful when fibromyalgia is paired with mood symptoms.
SNRI approved in the US exclusively for fibromyalgia. Similar descending pain inhibition mechanism to duloxetine with a stronger norepinephrine component. Often considered when duloxetine has been insufficient or not tolerated.
Beyond these three FDA-approved options, several drugs are commonly prescribed off-label for fibromyalgia: low-dose amitriptyline (Elavil), gabapentin (Neurontin), and cyclobenzaprine (Flexeril) all have established evidence and show up frequently in patient histories. Aerobic exercise and sleep optimization remain near-first-line non-pharmacological options. Ketamine evaluation at Vita Nova takes place in the context of an honest review of what's been tried, at what doses, and for how long.
Central Sensitization — And Why Mechanism Matters
Fibromyalgia is the prototypical central sensitization syndrome. NMDA glutamate receptors in the spinal cord and brain become hyperactive, amplifying signals and producing widespread pain, fatigue, and cognitive symptoms without any peripheral tissue damage. The 2010 American College of Rheumatology criteria removed the tender point examination requirement because fibromyalgia is a central nervous system diagnosis, not a peripheral musculoskeletal one.
To understand why ketamine may help when FDA-approved medications haven't, it helps to see what each medication actually does — and where in the central sensitization pathway it acts.
| Medication | How It Works | Limitation |
|---|---|---|
| Pregabalin (Lyrica) | Modulates calcium channel activity in sensitized neurons — addresses the downstream consequences of NMDA hyperactivity | Works around the NMDA problem rather than blocking the receptor driving it. Side effects (dizziness, weight gain, sedation) can limit tolerability |
| Duloxetine / Milnacipran | Strengthens descending pain inhibitory pathways — enhances the brain's natural pain suppression signals | Supports the body's counterbalance but doesn't block the NMDA receptor driving sensitization. Incomplete response is common |
| Amitriptyline | Weak NMDA activity plus noradrenergic pain modulation | NMDA effect is weak. Significant anticholinergic side effects limit use beyond low-dose sleep aid |
| Ketamine (IV) Off-Label | Direct NMDA receptor blockade — addresses the receptor driving central sensitization itself | Off-label. Requires an IV infusion in a clinical setting. Not first-line. Individual results vary. Larger long-term trials are still needed |
Ketamine's mechanism is the most direct pharmacological approach to fibromyalgia's core pathology that's currently available. That alignment is the clinical rationale for considering it when first-line treatments have not been enough — not because ketamine is universally effective (it isn't), but because the mechanism matches what fibromyalgia actually is.
The Fibromyalgia Triad — Pain, Fatigue, Fibro Fog
Fibromyalgia is not simply widespread pain. It's a triad of three features — all arising from the same underlying central sensitization. Understanding this is why treating only the pain dimension so rarely produces complete relief.
NMDA hyperactivity in the dorsal horn amplifies incoming signals — light touch becomes painful (allodynia) and painful stimuli feel more intense than they should (hyperalgesia). The pain is bilateral, above and below the waist, and shifts because it's generated centrally, not peripherally.
Fibromyalgia fatigue is profoundly different from being tired. A nervous system running in constant amplified pain processing depletes central energy at a rate sleep can't restore — particularly because pain disrupts the deep, restorative sleep stages. You wake exhausted regardless of hours slept.
Poor working memory, concentration trouble, slowed processing, word-finding problems. Research has identified changes in prefrontal and hippocampal function in fibromyalgia consistent with the cognitive burden of constant amplified pain processing.
The Evidence for Ketamine in Fibromyalgia — Both Halves of the Story
The evidence for ketamine in fibromyalgia is meaningful but not definitive. We tell you the response rates because patients deserve to know what's likely — and what isn't.
3-day in-hospital IV ketamine induction followed by hospital-compounded oral ketamine maintenance, with response classified at 3 months. Complete responders continued therapy a mean of 15.6 months; 58.5% eventually discontinued, most often for lack of efficacy or side effects. Read the study (DOI).
What this means: Roughly four in ten patients receive meaningful relief. Roughly four in ten do not. This is the honest picture — not the marketing picture. If you pursue ketamine evaluation at Vita Nova, we'll tell you during and after the induction series whether you're responding. If you're not, treatment isn't continued indefinitely.
A 2024 systematic review found only six published studies (115 patients in total) of ketamine in fibromyalgia. Most short-term studies showed a good pain response; the one study with 8-week follow-up did not. Side effects were common but appeared during the infusion and resolved within minutes. The authors concluded ketamine is effective in the short term and that larger, long-term follow-up studies are still needed — which is exactly why a maintenance model, and honest response assessment, matter.
Placebo-controlled study of 29 fibromyalgia patients given IV ketamine (0.3 mg/kg over 30 minutes). Seventeen were ketamine responders (over 50% pain reduction); in the responders, ketamine reduced muscle pain at rest, muscular hyperalgesia, temporal summation (wind-up), and referred pain spread. Established that NMDA receptor blockade interrupts the central hyperexcitability mechanisms characterizing fibromyalgia — in the subgroup that responds.
Early double-blind, placebo-controlled study in 31 fibromyalgia patients comparing IV morphine, lidocaine, and ketamine. Morphine produced no significant change; ketamine produced a significant reduction in pain intensity during and after the infusion, with decreased tenderness at tender points and increased endurance. Provided foundational evidence that fibromyalgia pain responds to NMDA blockade rather than to opioids.
Landmark clinical review establishing fibromyalgia as the prototypical central sensitization syndrome, with NMDA receptor dysregulation as the core mechanism. This characterization is the foundation for why ketamine's direct NMDA blockade is mechanistically aligned to fibromyalgia.
The Clinical Protocol — What Treatment Looks Like
Ketamine infusion therapy for fibromyalgia follows a defined clinical structure. The protocol below reflects current standards — the exact session count, dose, and maintenance schedule are determined individually during evaluation.
Your Care Pathway
The treatment journey at Vita Nova follows a clear sequence:
Consultation — a conversation about your fibromyalgia history, what you've tried, and what hasn't worked. No commitment.
Clinical evaluation — physician review of medical records, medication history, candidacy assessment, and informed consent.
Induction series — 5 to 10 infusions over 1 to 2 weeks. Response is assessed during and after.
Maintenance & coordination — if you respond, booster infusions on an individualized schedule. We coordinate with your rheumatologist, PCP, or therapist throughout.
If you don't respond — we say so. Treatment isn't continued indefinitely. We help coordinate alternative pathways through your existing care team.
Who Ketamine Evaluation May Help — And Who Shouldn't Pursue It
Honest gatekeeping is part of how we treat fibromyalgia patients. Not everyone is a candidate. The criteria below reflect how we evaluate candidacy — they're not absolutes, and final determination is always individual.
✓ Likely a Reasonable Candidate
- Confirmed fibromyalgia diagnosis from a qualified clinician
- Failed or insufficient response to at least one FDA-approved fibromyalgia medication at therapeutic dose
- Have tried non-pharmacological approaches (PT, sleep work, exercise)
- Are willing to coordinate with existing physicians
- Understand ketamine is off-label and not a cure
- Maryland resident, able to attend in-clinic in Canton, Baltimore
⚠ Should Not Pursue Without Further Workup
- No confirmed fibromyalgia diagnosis yet — see your PCP or rheumatologist first
- Have not tried any FDA-approved fibromyalgia medication
- Active untreated psychosis, mania, or substance use disorder
- Uncontrolled hypertension or significant cardiovascular disease
- Pregnancy or breastfeeding
- Seeking ketamine as a recreational alternative rather than a clinical treatment
Final candidacy is determined by clinical evaluation. Not all patients who complete evaluation are offered treatment. This is a feature of responsible care, not a bug.
Your First Session — Step by Step
Patients often arrive nervous — it's a reasonable response. Here's exactly what happens, from when you walk in to when you go home.
Check-In & Vital Signs
You arrive at 513 Bayview Blvd in Canton, Baltimore. Parking is free. You're shown to a private infusion room. Vital signs — blood pressure, heart rate, oxygen saturation — are taken before the infusion starts.
IV Placement & Settling In
An IV line is placed. You sit in a reclining chair with a blanket, dim lighting, and the option of an eye mask or music. The room is yours — quiet, private, comfortable. Clinical staff remain available throughout.
40–60 Minute Infusion
The ketamine infusion runs over approximately 40 to 60 minutes. You may feel mild dissociation — a sense of being slightly outside yourself or floating. Some patients find it interesting; some find it neutral; a few find it uncomfortable. The effect is dose-related and well-controlled. Vital signs are monitored continuously.
15–30 Minute Recovery
The dissociative effects fade rapidly after the infusion ends. You rest in the chair for 15 to 30 minutes until you feel clear and steady. Light nausea is occasional and managed.
Ride Home — Required
You cannot drive yourself home. Arrange rideshare, family, or a friend for transportation. Plan to rest the remainder of the day. Avoid driving, machinery, legal documents, or significant decisions until the following morning.
Physician-Led Care — Dr. Brijen L. Joshi MD
Ketamine is a medication, and an IV infusion is a medical procedure. At Vita Nova, fibromyalgia ketamine therapy is physician-led under the medical direction of Dr. Brijen L. Joshi MD — a board-certified anesthesiologist with an active Johns Hopkins faculty appointment. Anesthesiology is the medical specialty most directly trained in IV anesthetic dosing, titration, and physiological monitoring during dissociative drug effects. That training is exactly what a monitored ketamine infusion calls for — physician-led care, not a nurse-only or spa drip.
Dr. Joshi is a board-certified anesthesiologist and Assistant Professor of Anesthesiology & Critical Care Medicine at Johns Hopkins University School of Medicine. He brings deep training in IV anesthetic dosing, intraoperative vital-sign management, and the clinical use of dissociative agents — the skill set most directly relevant to careful, monitored ketamine infusion therapy.
Co-Occurring Conditions — Why They Matter for Your Pathway
Fibromyalgia rarely arrives alone. The comorbidity picture is well-documented — and it shapes which treatment pathway makes the most sense for you.
Why this matters clinically: these aren't unrelated coincidences. Fibromyalgia and these comorbidities share neurobiological mechanisms — NMDA receptor dysregulation, impaired prefrontal function, disrupted stress response, neuroinflammation. Because ketamine's NMDA blockade is mechanistically relevant across several of these overlapping conditions, a single evaluation considers your whole clinical picture rather than treating fibromyalgia in isolation. If depression or another documented condition travels with your fibromyalgia, your provider evaluates both dimensions in one plan — see our co-occurring depression & chronic pain page.
Pricing & Payment
| Service | Non-Member | Vitality Circle Member | Saving |
|---|---|---|---|
| Ketamine — Fibromyalgia / session Off-Label | $1,499.99 | $1,125 | $374.99/session |
Self-pay, with a superbill. Vita Nova is self-pay for ketamine. Each $1,499.99 session is a private, continuously monitored infusion under the medical direction of Dr. Brijen L. Joshi MD, a board-certified Johns Hopkins anesthesiologist — physician-led care throughout. Vitality Circle membership ($99.99/month) lowers each session to $1,125; the $374.99 saved covers the membership on a single visit, and members also receive 25% off premium IVs (NAD+, high-dose Vitamin C, Iron) plus one included monthly perk (1 standard IV drip, 2 IM shots, 2 IV pushes, or 1 shot + 1 push). We provide an itemized superbill you can file with your insurance. HSA and FSA cards are accepted for every session, and Community Heroes discounts are available. Number of sessions is determined individually at evaluation. Pricing August 2026 — subject to change. Full pricing guide →
Complementary Treatments — Not Replacements
Several wellness services address physiological deficits common in fibromyalgia. These are not fibromyalgia treatments and are not part of Vita Nova's ketamine clinical protocols. Always discuss with your prescribing physician.
Magnesium deficiency is common in fibromyalgia and naturally modulates NMDA receptor sensitivity. Restoring magnesium may complement ketamine's NMDA-related mechanism. Discuss with your physician.
Low iron and low ferritin are common in fibromyalgia and are linked to worse fatigue and to restless legs syndrome, which fragments the deep sleep fibromyalgia patients already struggle to get. When bloodwork confirms deficiency, IV iron restores stores faster than oral supplements many patients tolerate poorly.
Mitochondrial dysfunction is documented in fibromyalgia. NAD+ IV supports cellular energy production at the mitochondrial level — relevant to fibromyalgia fatigue.
Vitamin D3 deficiency is highly prevalent in fibromyalgia and associated with worsened pain severity. Limited mobility further reduces sun-mediated D3 synthesis.
B vitamins support neurotransmitter synthesis pathways depleted by long-term SNRI use — common in fibromyalgia patients on duloxetine or milnacipran.
Clinical note: These wellness services are not treatments for fibromyalgia. Always discuss supplemental therapy with your prescribing physician — particularly regarding interactions with pregabalin (Lyrica), duloxetine (Cymbalta), or milnacipran (Savella).
Special Pricing for Those Who Serve
Fibromyalgia is disproportionately prevalent among veterans, nurses, and teachers — populations with high rates of physical and psychological stress, sleep disruption, and untreated PTSD, all of which are established fibromyalgia risk factors.
Fibromyalgia & Ketamine — Common Questions Answered
Real, high-intent questions from fibromyalgia patients evaluating ketamine and IV therapy in Baltimore.
A Conversation,
Not a Commitment
If standard fibromyalgia treatments haven't been enough, the next step is talking with us. We review your full history, what's been tried, and whether ketamine evaluation may be a reasonable next step — or whether it isn't. Honest gatekeeping. Off-label use disclosed throughout. Self-pay with an itemized superbill you can file with your insurance.
Canonical URL: https://vitanovawellnessclinic.com/fibromyalgia-treatment-baltimore/ · Last reviewed August 26, 2026
Medically reviewed by Dr. Brijen L. Joshi MD — Assistant Professor of Anesthesiology & Critical Care Medicine, Johns Hopkins University School of Medicine · Chief of Thoracic Anesthesia, Johns Hopkins Hospital · Medical Director, Vita Nova Ketamine & Wellness Clinic. · View full credentials →
